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BIOKOMPOSIT APATIT TERTUKAR GANTI/POLI-EPSILON 
KAPROLAKTON SEBAGAI SUBSTRAT DAN SALUTAN KE ATAS BUSA 
ALPHA-TRIKALSIUM FOSFAT  
ABSTRAK 
Dalam kajian ini, biokomposit karbonat dan silikon tertukar ganti apatit/poli-epsilon-
kaprolakton (CO3Ap/PCL) dihasilkan untuk digunakan sebagai pengganti tulang 
biokomposit berliang. Di samping itu, CO3Ap/PCL juga disalut ke atas busa α-
trikalsium fosfat (α-TCP) untuk meningkatkan sifat mekanikal dan biologi serta 
mencapai struktur tulang cancellous. Apatit karbonat (CO3Ap) dan silikon tertukar 
ganti karbonat apatit (Si-CO3Ap) telah disintesis melalui kaedah pemendakan. 
Keputusan menunjukkan bahawa ion silikat dan karbonat bersaing untuk menduduki 
tapak fosfat dan juga memasuki secara serentak ke dalam struktur hidroksiapatit. Si-
tertukar ganti CO3Ap mengurangkan kehabluran serbuk dan menggalak pembebasan 
ion yang mengakibatkan kelarutan yang lebih baik berbanding dengan CO3Ap bebas 
Si. Penggantian serentak silikon dan karbonat didapati mempunyai kesan yang lebih 
baik pada peringkat awal kelakuan osteoblast (pendampingan dan pembiakan sel) 
tetapi tidak pada peringkat semasa/akhir (pembiakan dan pembezaan). Penghasilan 
biokomposit yang diterbitkan daripada Si-CO3Ap berliang sambung yang 
diperkukuhkan dengan PCL lebur telah dibangunkan untuk meniru komposisi dan 
struktur tulang yang ditokok dengan prestasi mekanikal yang lebih/baik. Blok 
karbonat apatit yang digantikan silikon telah dihasilkan menggunakan lilin sebagai 
ejen meruap. Si-CO3Ap berliang sambung yang diperolehi mempunyai keliangan 
kira-kira 80% dan saiz liang kira-kira 100-200 μm. PCL melitupi dan menembusi 
liang Si-CO3Ap berliang untuk membentuk suatu ikatan yang baik dengan Si-CO3Ap 
dan ini membawa kepada peningkatan yang ketara kekuatan tegangan lintang dari 
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0.23 MPa kepada nilai maksimum 2.04 MPa. Walaupun biokomposit berliang ini 
sedikit sebanyak menepati keperluan tulang biologi, masih wujud satu cabaran besar 
untuk menghasilkan bahan pengganti tulang ideal yang menepati struktur semulajadi. 
Suatu struktur yang saling bersambung sepenuhnya perlu dipertimbangkan. Kelakuan 
mekanikal, mikrostruktur dan tindakbalas sel α-trikalsium fosfat (α-TCP) yang 
menyaluti busa CO3Ap/PCL telah dikaji sebagai langkah awal untuk menghasilkan 
pengganti tulang jenis cancellous. Busa α-TCP telah diperolehi dari pada pensinteran 
CaCO3 dan CaHPO4•2H2O pada suhu 1500
o
C. Ia kemudiannya disalut dengan 
CO3Ap/PCL dan struktur bersambung liang tiga dimensi sepenuhnya telah 
dikekalkan. Salutan CO3Ap/PCL ke atas busa α-TCP telah terbukti sangat berkesan 
untuk meningkatkan kekuatan mekanikal dan keliatan busa α-TCP selain 
mempamerkan kebioserasian yang cemerlang. Sampel α-TCP bersalut 
mempamerkan keliangan tinggi (80-85%) dengan saiz liang yang besar (500-700μm) 
yang menepati struktur tulang cancellous. Penilaian biologi in vitro menunjukkan 
bahawa CO3Ap/PCL yang digunakan dalam salutan meningkatkan dampingan  dan 
pembiakan sel serta menggalakkan aktiviti alkali fosfatas bagi kedua-dua sel 
MC3T3-E1 sel sumsum tulang tikus. 
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SUBSTITUTED APATITE/POLY-EPSILON-CAPROLACTONE 
BIOCOMPOSITE AS SUBSTRATES AND COATING ON ALPHA-
TRICALCIUM PHOSPHATE FOAMS 
ABSTRACT 
In this research, carbonate and silicon-substituted apatite/poly-ɛ-caprolactone 
biocomposite were produced to be used as a porous biocomposite bone substitute. 
Carbonate apatite/poly-ɛ-caproplactone (CO3Ap/PCL) was also used to coat on a 
fully interconnected structure of α-tricalcium phosphate (α-TCP) foam to enhance the 
mechanical and biological properties, and to mimic the structure of cancellous bone. 
Carbonate apatite (CO3Ap) and silicon-substituted carbonate apatite (Si-CO3Ap) 
were synthesized by a precipitation method. The results revealed that the silicate and 
carbonate ions competed to occupy the phosphate site and also entered 
simultaneously into the hydroxyapatite structure. The Si-substituted CO3Ap reduced 
the powder crystallinity and promoted ion release which resulted in a better solubility 
compared to that of Si-free CO3Ap. The silicon and carbonate co-substitution 
appeared to have a better effect on the early stages of osteoblast behavior (cell 
attachment and proliferation) rather than the immediate/late stages (proliferation and 
differentiation). The fabrication of a biocomposite derived from an interconnected 
porous Si-CO3Ap reinforced with molten poly-ε-caprolactone (PCL) was then 
developed to mimic the composition and structure of bone coupled with enhanced 
mechanical performance. Porous silicon-substituted carbonate apatite blocks were 
produced using wax as a volatile agent. The interconnected porous Si-CO3Ap 
obtained has a porosity of about 80% and a pore size of about 100-200 µm. The PCL 
covered, and penetrated into the pores of, the porous Si-CO3Ap to form an excellent 
bonding with Si-CO3Ap leading to a significant increase in diametral tensile strength 
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from 0.23 MPa to a maximum of 2.04 MPa. However, although the porous 
biocomposite meets the requirement of biological bone to some extent, it remains a 
great challenge to make the ideal bone substitute materials that mimic the natural 
structures, in which, a fully interconnected structure should be highly considered. 
The mechanical behavior, microstructure and cell responses of CO3Ap/ PCL coated 
α-tricalcium phosphate (α-TCP) foams were studied as an initial step for the 
fabrication of a cancellous-type artificial bone replacement. The α-TCP foam was 
obtained by sintering CaCO3 and CaHPO4•2H2O at 1500
o
C. It was then coated with 
CO3Ap/PCL and its three dimensional, fully-interconnected porous structure was 
found to be maintained. CO3Ap/PCL coating on α-TCP foam was proven to be very 
effective in increasing the mechanical strength by 25 times and toughening the α-
TCP foam, in addition to excellent biocompatibility as proven by bone marrow cell 
studies. The coated α-TCP specimens exhibited high porosity (80-85%) with large 
pore size (500-700µm) that mimic the cancellous bone structure. The in vitro 
biological evaluations indicated that CO3Ap/PCL used for coating improved cellular 
attachment, accelerated proliferation and resulting in a greater alkaline phosphatase 
(ALP) activity of both MC3T3-E1 cell-like and rat bone marrow cells.  
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CHAPTER 1 
INTRODUCTION 
 
1.1  Background  
The reconstruction of bone defects is a common challenge in the medical and 
dental fields. At present, the golden standard for the reconstruction of bone defect is 
the use of autograft and allograft, in which treatment typically focuses on harvesting 
tissue from one site to another in the same patient (an autograft) or from one 
individual to another (allograft) [1, 2]. However, there are serious drawbacks with 
these two techniques. Harvesting autografts is expensive, painful, and limited supply 
whilst allografts have serious constraints of transplantation due to the possibility of 
introducing infection or disease from the donor to the patient [1, 3, 4]. Therefore, 
artificial bone replacement materials appear to be ideal for clinical applications.  
Bioceramics made of calcium phosphates (CaP) appear to be very prominent 
due to the excellent biocompatibility, bone bonding ability, and provide the 
advantage of chemical composition similarity to natural bone [2, 5, 6].  About 60 
wt% of bone is made of hydroxyapatite (HA: Ca10(PO4)6(OH)2), and therefore, HA 
and other calcium phosphates (e.g. tricalcium phosphate (TCP), biphasic calcium 
phosphate) have been intensively studied as the major component of bone substitute 
materials [7-11]. Calcium phosphates have the distinct physiochemical advantages of 
stability, inertness, and biocompatibility [12].  
 
It is well known that the incorporation of carbonate ions has considerable 
impact on the crystal lattice of apatite structure, and on the mineralization process. 
Introduction of carbonate ions in HA increases the dissolution rate and could 
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enhance the osteointegration rate [10,13,14]. Therefore, carbonate-substituted 
hydroxyapatite or carbonate apatite (CO3Ap) is a prospective candidate for bone-
substitute material in order to mimic the composition of bone tissue. In addition, 
CO3Ap is resorbed faster by osteoclasts and replaced with the new bone at a higher 
rate compared to HA [15]. 
 
Apart from carbonate, silicon substitution in apatites had also been reported 
to enhance and stimulate osteoblast-like cell activity [16], and promotes bone 
remodeling processes [17]. The solubility was observed to increase with an increase 
in structural order due to the presence of foreign ions (i.e. CO3
2-
, SiO4
4-
) [18-20] in 
the HA structure. In addition, Si substitution is also able to promote ion releases 
which are essential for the biological processes [21]; nonetheless only a few research 
have investigated ion release in synthetic fluids [20] and the cell response. Therefore, 
the development of synthetic HA powders with a fully completed and controlled 
level of ionic substitutions in the HA lattice is of great importance in order to 
approach the natural bone.  
 
After obtaining materials which mimicked the chemical composition of bone 
mineral, the biological performance was considered as another key issue for the 
application of calcium phosphate (CaP) in tissue engineering [22], in which cell 
activities are of fundamental importance in ensuring successful osteointegration. This 
biological response is influenced by the geometry, chemical composition and 
morphology of a bone-substitute material [2]. In addition, bone substitute materials 
with porous structure have a strong bonding with mineral bone and provide a 
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mechanical interlocking caused by ingrowth of bone tissue into the pores [23], and as 
such, porous CaPs are preferred in clinical application [24]. 
 
1.2  Problem statement 
Numerous research works had focused on the synthesis of HA biomaterial 
substituted with single- or multi-ion substitution of CO3
2-
 [25, 26], Si [19, 27-29], F 
[8], Fe [30], etc, whereas the substitution of CO3
2-
 along with other cations in the 
apatite structure were restricted to the co-substitution of HA with the ionic pair of 
Mg
2+
/CO3
2-
[9, 31], Sr
2+
/CO3
2-
 [32] and Na
+
/CO3
2-
 [33]. Although a few research had 
been carried out on the synthesis of SiO4
4-
/CO3
2-
 co-substitution in HA [21, 34], it is 
not clearly apparent whether SiO4 present in the material completely substituted for 
the PO4
3-
 in the HA structure, or whether the replacement was partial. It was reported 
[18] that both CO3
2-
 and SiO4
4-
 reduced HA crystallinity, and the structure could host 
only a limited amount of the two ions before collapsing. Additionally, the final 
product contained CO3 and SiO4, but there was a lack of experimental evidence on 
the substitution of these ions i.e. the competition evidence between CO3 and SiO4 for 
substituting the PO4 ions. Recently, an extensive study on the SiO4 and CO3 co-
substituted HA had been reported [33]. However, the preparation methods were 
carried out under air atmosphere and used CO2 from the atmosphere as the CO2 
source, and as such, there was no control of CO3 substitution level. Thus, the CO3 ion 
present could indeed be doped-HA, where the foreign ion is just adsorbed on the 
surface of the crystals [18]. Moreover, the mechanical properties and cell activity of 
the ion-substituted HA after heat-treatment were not fully considered. 
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Against this background, the first part of this research project was to prepare 
and characterize carbonate apatite and silicon-substituted carbonate apatite by a 
precipitation method. The result was aimed to provide an accurate understanding of 
the changes in hydroxyapatite (apatite) caused by the co-substitution of carbonate 
(CO3
2-
) and silicate (SiO4
4-
) ions on the structure, solubility of as-synthesized Si-
CO3Ap powders and mechanical properties. Additionally, the biocompatibility was 
also studied by performing cell attachment, cell morphology, proliferation and 
differentiation using rat bone marrow cells and MC3T3-E1 osteoblast-like cells on 
the CO3Ap and Si-CO3Ap specimens (as-synthesized and heat-treated compacts). 
 
It was reported that a porous structure of about 50-90% porosity with 
appropriate pore size is necessary for bone tissue formation [35,36] whilst the 
interconnected porous structure is important in the early stages of bone regeneration 
[37], to facilitate the penetration of mesenchymal cells and osteotropic agents into 
the pores [38]. The pores should be large enough to allow for cell penetration and 
adhesion, whilst smaller pores allow for nutrients and oxygen diffusion throughout 
the scaffold [39].  
 
However, the porosity and structural architecture of porous CaPs significantly 
affect their mechanical properties, where the strength decreases when the porosity 
increases [40, 41]. It had been shown that the mechanical properties of a ceramic 
material can be strengthened by the incorporation of a ductile polymer [2,42,43]. 
Inherently, natural bone is made up of a biological mineral of CaP and about 40wt% 
of bioorganic polymers (mainly collagen type I) [2, 44], which is accountable for the 
superior strength and partial elasticity in biological calcified tissues [45]. Therefore, 
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the consequent strategy is to combine polymers and CaPs to fabricate scaffolds that 
meet the requirements desired for bone applications. The fabrication of a 
biocomposite derived from the interconnected porous CaP reinforced with poly-ε-
caprolactone (PCL) was then produced to mimic the composition and structure of 
bone coupled with enhanced mechanical performance.  
 
Although a porous CaP/PCL biocomposite meets the requirement of 
biological bone to some extent, it remains a great challenge to make the ideal bone 
substitute materials that mimic the natural structures, in which, a fully interconnected 
structure should be highly considered. Among many porous calcium phosphate 
(CaP), CaP foam gained much attention since it has a fully interconnected porous 
structure, similar to that of cancellous bone, and high porosity of more than 90%. Up 
to date, hydroxyapatite foam, α-TCP foam, carbonate apatite (CO3Ap) foam, and 
biphasic calcium phosphate foam are the CaP foams reported and studied [5-8]. 
Although fully interconnected porous structure and large porosity are ideal from a 
biological point of view, it results in limited mechanical strength. Recently, poly 
(lactic-co-glycolic) acid (PLGA) coating on CO3Ap foam was reported to be 
effective in improving the mechanical properties of CO3Ap foam [9]. However, 
fabrication of CO3Ap foam is complex since CO3Ap is unstable at the high 
temperatures required for the sintering process. In contrast, α-TCP is stable at high 
temperature and is also a biodegradable calcium phosphate.  
 
 Coating a polymer on a porous calcium phosphate (CaP) is an alternative 
method to produce scaffolds with good mechanical strength whilst maintaining high 
porosity and large pore size. On the other hand, CaP was incorporated with the 
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polymer in order to improve the biocompatibility of the material [43]. This mixture 
had shown to be more effective for the enhancement of bioactivity [46]. For 
example, the incorporation of HA in poly-ε-caprolactone (PCL) matrix of the 
HA/PCL scaffold showed better adhesion, proliferation of fibroblasts and protein 
adsorption compared to single HA or single PCL controls [47]. Thus, in this research 
project, the CO3Ap was hybridized with PCL and coated on the α-TCP foam.  
 
1.3 Objective of the research 
This study is focused on the preparation of silicon and carbonate substituted 
hydroxyapatite/poly-ɛ-caprolactone biocomposite as substrate and coating on α-
tricalcium phosphate foams with high performance properties which can be applied 
in biomedical technology. Therefore, the main objectives are: 
1. To investigate the simultaneous substitution of SiO4
4-
 and CO3
2-
 ions into the 
HA structure in order to obtain a product which is closer in chemical composition to 
the natural bone. The competition between CO3
2-
 and SiO4
4-
 for substituting the PO4
3-
 
ions in the HA structure was also investigated. The aim of the work was also to 
evaluate the physical and mechanical properties and the solubility, as well as in vitro 
cell study of the silicon-substituted carbonate apatite as compared to that of 
carbonate apatite.  
2. To mimic the composition and structure of bone coupled with enhanced 
mechanical performance. The fabrication of a biocomposite derived from an 
interconnected porous Si-CO3Ap reinforced with PCL was developed. 
3. In order to mimic the porous structure of cancellous bone which is 
responsible for 88% of the amount of the bone remodeling, the fully interconnected 
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structure of CO3Ap/PCL coated α-TCP biocomposite was fabricated. The mechanical 
properties and in vitro cell culture of the biocomposite was studied 
 
1.4 Project overview 
This research work is divided into three parts which will be described in 
detail in CHAPTER 3. The first part is synthesis and characterization of CO3Ap and 
Si-CO3Ap, in which a precipitation method with the optimized parameters [48, 49] 
adapted. The precipitation method allows the production of materials with good 
crystallinity, physiological stability and with the morphological characteristics of the 
bone tissue. Additionally, this is a low-cost, simple and versatile technique. 
Separately, during the reactions, the reaction media involves no foreign elements 
except water, the only by product. The second part is the fabrication of a porous 
structured Si-CO3Ap/poly-ε-caprolactone (PCL) biocomposite derived from porous 
Si-CO3Ap block and PCL infiltration.  
 
The final part is the use of CO3Ap/PCL coating on α-TCP foam to produce a 
fully interconnected porous structure with very high porosity and large pore size to 
mimic the cancellous bone-type replacement. The coating of PCL is also made as a 
control. The influence of PCL concentration solution and CO3Ap content on the 
mechanical properties as well as cell response was investigated. In summary, the 
scope of research is presented in Fig. 1.1. 
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Fig. 1.1 Flow chart of the research 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Introduction  
Calcium phosphate ceramics have received considerable attention as artificial 
bone substitutes because of their excellent tissue compatibility and osteoconductivity 
[12, 50]. Some of the most commonly used calcium phosphate ceramics are 
hydroxyapatite (HA) and tricalcium phosphate (TCP) (α and/or β form) [2, 6]. 
Hydroxyapatite (HA) is the key bioceramic material used for artificial bone 
substitute because it is found in natural hard tissues as a mineral phase [51]. A 
remarkable property of the synthetic HA is its excellent bioactivity, which is the 
ability to form bone bonding after implantation. However, even if the 
biocompatibility of HA is excellent, the bioactive process in HA shows some 
shortcomings when compared with other bioactive materials [52], i.e. the bioactivity 
reactions in silica based glasses take only a few minutes whilst those in HA take 
several days [29]. In addition, sintered HA have a low solubility rate, and so, it is 
slowly adsorbed by osteoclast and resulted in a slow replacement by the new bone 
[15, 53]. In contrast, alpha tricalcium phosphate (α-TCP) is the most soluble 
compounds among the calcium phosphates. Thus, when fast bone remodeling is 
desired, α-TCP can be applied. 
 
It is believed that the introduction of carbonate ions and/or silicon ions in the 
HA would increase its dissolution rate in solution and could enhance its 
osteointergration rate in vivo [32, 54]. Thus, carbonate apatite (CO3Ap) and silicon-
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substituted carbonate apatite (Si-CO3Ap) are the other prospective materials for the 
preparation of bone substitute materials. 
 
Although calcium phosphate (CaP) ceramics have received wide attention for 
biological applications due to their high bioactivity and osteoconductivity [5, 18], the 
applications of CaPs have been limited due to their inherent brittleness, low elasticity 
and low fracture toughness [2]. In addition, the biological performance is another key 
issue for the application of CaP in clinical uses [22], in which cell activities are of 
fundamental importance in ensuring successful osteointegration. This biological 
response is influenced by the geometry, chemical composition and morphology of a 
bone-substitute material [2]. For a compact, synthetic CaP, only the surface is in 
contact with the tissue. Thus, porous CaPs are preferred in clinical applications [24]. 
 
This review will provide an overview of bone structures, bone cells in bone 
remodeling processes, as well as the use of biomaterials in tissue engineering. 
Particularly, bioceramic materials, as a part of biomaterials, will be discussed in 
more detail in this review. Material selection of biocomposite will also be explained. 
The final part of this review will address the cell-material interactions, and some 
evaluation techniques on the biological performance of materials are briefly 
explained. 
 
2.2  Bone Tissue 
Bone is one of the most complex constituents of the body and this is due to 
the multiple functions that it has to perform [5]. It is a living material composed of 
cells and a blood supply covered by a strong, interwoven composite structure [55]. 
11 
 
The composite is formed by an organic matrix (30wt% of collagen type I) and 
inorganic mineral nanocrystals of an apatite phase (70t%). The inorganic phase of 
bone is composed of an impure version of hydroxyapatite, in which carbonate (3-8 
wt%) and other ions i.e. Si
4+,
 Na
+
, Mg
2+
, K
+
, F
-
, Cl
-
, etc  are substituted into its 
structure [9,10, 27,56,57]. This mineral component gives rise to the compressive 
strength of bone whilst the organic component is responsible for bone toughness and 
plasticity [2,58,59]. Table 2.1 shows the comparative composition of human enamel 
and bone. 
Table 2.1 Composition of the human enamel and bone [60] 
Constituent Bone (wt%) In enamel (wt%) 
Calcium, Ca
2+
 
Phosphorus, P
3+
 
Ca/P molar ratio 
Sodium, Na
+
 
Potassium, K
+
 
Magnesium, Mg
2+
 
Carbonate, CO3
2-
 
Fluoride, F
-
 
Chloride, Cl
-
 
Silicon, Si
4+
 
24.50 
11.50 
1.65 
0.70 
0.03 
0.55 
5.80 
0.02 
0.10 
0.003 
36.00 
17.70 
1.62 
0.50 
0.08 
0.44 
3.20 
0.02 
0.30 
0.04 
 
In addition, bones are also involved with blood cell formation, calcium 
metabolism and act as a mineral storage. Bone also contains bone-forming cells 
(osteoblasts) and bone-resorbing cells (osteoclasts) with various growth factors and 
molecules [61]. Bone provides the cells in the marrow that differentiates into blood 
cells, providing mechanical support for the soft tissue and serving as an anchor for 
the muscles that generate motion [62].  
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The major support bones consist of an outer layer of cortical (or compact) 
bone (density ≈ 1.80 g/cm3) covering an internal spongy structure of cancellous bone, 
which has a porosity of 75-95 % and a density of about 0.2 g/cm
3
 [58, 59, 63] (Fig. 
2.1). The porosity reduces the strength of bones but also reduces their weight. Bone 
architectural properties (cortical thickness, porosity, level of mineralization and 
properties) derived from the organic phase of bone influenced the load bearing 
ability of bone [59].  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.1 General structure of a mammalian bone [59] 
 
There are some critical physical and chemical characteristics of bone 
including: (i) interconnected porosity; (ii) biodegradability (remodeling); (iii) 
bioactivity; (iv) osteoconductivity and (v) osteoinductivity. Pore size in normal 
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cortical bone ranges from 1 to 10 µm, and 200-400 µm in the trabecular bone. In 
order to promote bone formation, repair or regeneration, the size and interconnection 
of the porosity is critical for the diffusion of nutrients, cell attachment, migration, 
proliferation and differentiation [61]. 
 
Differences in mechanical properties depend on the compartment of bone 
(cortical vs. trabecular bone) as well as the bone orientation. Cancellous bone has a 
lower modulus of elasticity and a higher strain to failure than a cortical bone [55]. 
The primary function of trabecular bone (cancellous bone) is to direct stresses to the 
denser cortical bone [64]. Table 2.2 gives some information about the mechanical 
properties of bone tissues. 
 
Table 2.2 Mechanical properties of cortical and cancellous bones [55] 
Property Cortical Cancellous 
Compressive strength (MPa) 100-230 0.1-30 
Tensile strength (MPa) 50-150 10-20 
Strain to failure 1-2 5-7 
Young’s Modulus (GPa) 7-30 0.01-2 
 
2.3  Structure of cancellous bone 
80% of bone is comprised of dense cortical bone but the cancellous bone is 
responsible for 88% of the amount of the normal bone remodeling, mainly due to its 
macroporosity (100μm<pores<1500μm) [65].  
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(a) (b) 
Cancellous bone consists primarily of lamellar bone, arranged in packets that 
make up an interconnected irregular array of plates and rods, called trabeculae (Fig. 
2.2). The morphology of a trabeculae material is commonly described as an 
anisotropic composite of hydroxyapatite, collagen, water and trace amounts of other 
proteins [66]. The pore is filled with bone marrow. The percentage volume of water, 
inorganic and organic phases for hydrated trabeculae have been reported at 27%, 
38% and 35%, respectively [67].  The orientation of the trabeculae is affected by the 
mechanical stress to which the bone is subjected to.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.2 Hierarchical structure of bone: (a) selection through a femur head showing 
the shell of the trabecular (spongy bone) and the cortical (compact bone), (b) SEM 
image of the cancellous bone showing the high porosity and the interconnecting 
network of pores (magnification: 40X)  
 
2.4  Scope of tissue engineering 
Most tissues are unable to regenerate when injured or diseased. Even tissues 
that are able to regenerate spontaneously may not completely do so in large defects. 
Therefore, tissue engineering has become promising alternative therapy in which 
organs or tissues can be repaired, replaced, or regenerated [69] 
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Tissue engineering involves the development of a new generation of 
materials or devices capable of reconstruction or integration with biological tissues 
[69]. The cells are central to the regenerative process of any musculoskeletal tissue. 
They must ultimately be capable of integrating into the host tissue and synthesizing 
appropriate extracellular matrix.  Osteoblasts not only play a central role in bone 
formation by synthesizing multiple bone matrix proteins, but regulate osteoclast 
maturation by soluble factors and cognate interaction, resulting in bone resorption 
[70]. The biomatrix or a bone substitute material used in tissue engineering must 
have several functions, including a delivery vehicle for the cells or bioactive factors, 
acts as a template for tissue regeneration [71].  
 
It is needed to distinguish between cell therapy (also called as regenerative 
medicine) and tissue engineering. Cell therapy is to inject cell to the patient and 
allow it to grow and differentiate without the assistant of a matrix material or 
scaffold for medical treatment.  Tissue engineering, however, is to provide a guiding 
and scaffolding framework for cells to adhere to, expand, differentiate, and produce 
matrices for new tissue formation [69]. Therefore, tissue engineering is especially 
useful in cases where the lost tissues or organs are three-dimensional, bulky complex 
structure that cell therapy alone is not effective as a cure because it difficult to 
control the colonization of transplanted cells [69, 72]. 
 
2.5  Artificial bone substitutes  
The development of new artificial materials for the repair of bone defects is a 
great challenge for orthopedic and dental surgery. In order to overcome the limited 
service lives of implant devices, the emphasis in the development of bone substitutes 
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is now redirected from bone replacement towards bone tissue regeneration [73]. 
Numerous artificial bone substitutes are produced from a variety of biomaterials. 
When determining the suitability of a scaffold for use in tissue engineering, a number 
of key considerations are important: 
 
(i) Biocompatibility 
Biocompatibility is the very first criterion of any scaffold for tissue 
engineering. The ideal scaffolds should have an appropriate surface chemistry and 
microstructures to facilitate cellular attachment, proliferation and differentiation [71]. 
After implantation, the scaffold should elicit a negligible immune reaction in order to 
prevent it causing a severe inflammatory response that it might reduce healing or 
cause rejection by the body [1]. 
 
(ii) Biodegradability 
One of the scopes of tissue engineering is to allow the cells, over time, to 
eventually replace the implanted scaffold, i.e. to produce a new bone [74]. Thus, the 
substitute materials must be biodegradable so that the cells can be absorbed to 
produce their own extracellular matrix. The by-product of this degradation process 
must be non-toxic or cause inflammatory response to other organs. 
  
(iii) Mechanical properties 
Ideally, the scaffold must be strong enough to allow surgical handling during 
implantation. The scaffolds must have a sufficient mechanical support to function 
from the time of implantation to the completion of the remodeling process [50]. In 
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order to support bone ingrowth, the scaffold should not only be osteoconductive but 
also have adequate mechanical properties to provide initial stability [74].  
 
(iv) Scaffold architecture 
The architecture of scaffolds used for tissue engineering is of critical 
importance [1]. Since bone is a porous tissue material, there is a physiological 
rationale for the use of porous scaffold in its replacement of bone defects [75]. A 
bone graft substitute is a fully interconnected porous structure that acts as a template 
for the bone ingrowth. It was reported that a porous structure of about 50-90% 
porosity with appropriate pore size is necessary for bone tissue formation [35, 36] 
whilst the interconnected porous structure is important in the early stages of bone 
regeneration [37], to facilitate the penetration of mesenchymal cells and osteotropic 
agents into the pores [38]. The pores should be large enough to allow for cell 
penetration and adhesion, whilst smaller pores allow for nutrients and oxygen 
diffusion throughout the scaffold [39].  
 
2.6  Biomaterial 
Biomaterial is a term used to indicate materials that constitute parts of 
medical implants, extra-corporeal devices and disposables that have been utilized for 
implantation within, or incorporation with, a living system to supplement or replace 
functions of living tissue or organs [76, 77]. The most commonly used term to 
describe appropriate biological requirements of a biomaterial is biocompatibility. 
Biomaterial devices used in orthopaedics are commonly called implants. As a simple 
definition, biomaterial can be defined as a synthetic material suitable for implanting 
in a living body to repair damaged or diseased parts [72].  
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The selected biomaterial should be biodegradable and bioresorbable to 
support the reconstruction of a completely normal tissue without inflammation. The 
degradation products must be removed from the body via metabolic pathways [72]. 
The success of biomaterial in the body depends on factors such as the material 
properties, design and biocompatibility of the material used [78]. Biomaterials 
provide a cell-adhesion substrate and can be used to achieve cell delivery with good 
loading and efficiency to specific sites in the body [79].  
 
The biomaterials should provide adequate mechanical support sufficient to 
withstand in vivo forces exerted by the surrounding tissue and maintain a potential 
space for tissue development [72, 80], such as strength, stiffness and fatigue. 
 
Biomaterials can broadly be classified as biological biomaterials (soft and 
hard tissue type) and synthetic biomaterials (metallic, polymeric, ceramic and 
composite materials). Each type of synthetic biomaterial has advantages and 
disadvantages in properties as well as processibility. Metallic biomaterials have 
mechanical reliability that other biomaterials could not be obtained. Ceramic 
biomaterials have excellent biocompatibility upon implantation in the body whereas 
polymeric materials are easy to manufacture to produce various shapes with desired 
mechanical and physical properties. Some examples of biomaterials are provided in 
Table 2.3. 
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Table 2.3 Materials for use in the body [76] 
Material Advantages Disadvantages Examples 
Polymer (nylon, 
silicone rubber, 
polyester, 
polytetrafuoroethylene, 
etc.) 
 
Resilient 
Easy to fabricate 
Not strong 
Deform with time 
May degrade 
Sutures, blood 
vessels, hip 
socket, 
ear, nose, other 
soft tissues, 
sutures 
Metals (Ti and its 
alloys, Co-Cr alloys, 
stainless steels, Au, 
Ag, Pt, etc.) 
 
Strong, tough, 
ductile 
May corrode, 
dense, difficult to 
make 
Joint 
replacements, 
bone plates 
and screws, 
dental root 
implants, pacer 
and suture wires 
Ceramics (aluminum 
oxide, calcium 
phosphates including 
hydroxyapatite, 
carbon) 
 
Very 
biocompatible, 
inert, strong in 
compression 
 
Brittle, not 
resilient, 
difficult to make 
 
Dental; femoral 
head of hip 
replacement, 
coating of dental 
and orthopedic 
implants 
Composites (carbon-
carbon, wire or fiber 
reinforced bone 
cement) 
Strong, tailor-
made 
Difficult to 
fabricate 
Joint implants, 
heart valves 
 
2.6.1  Functions and requirements of biomaterials in tissue engineering 
In tissue engineering, biomaterials replicate the biologic and mechanical 
functions of the native extracellular matrix (ECM) found in body tissues by serving 
as an artificial ECM. 
 
Since the majority of mammalian cell types are anchorage dependent, the cell 
will die if there is no substrate for adhesion. Biomaterial provides a substrate that 
bone cell can adhere and deliver cells to specific sites in the body with high loading 
efficiency [81]. Biomaterial can also serve as a cell delivery vehicle, as a drug 
carrier, to activate specific cellular function in a localized region, and as a barrier 
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membrane to provide space for tissue regeneration along with the prevention of 
fibroblast ingrowth into the space [69]. 
 
Depending on the tissue sites as well as the applications, there are different 
requirements for mechanical properties of the biomaterials. The properly chosen 
biomaterial should allow the engineered tissue to maintain sufficient mechanical 
integrity to support itself in early development, while in late development it should 
begin degradation such that it does not hinder further tissue growth [82].  
 
Degradation and absorption of biomaterial are essential in functional tissue 
regeneration, unless the application is aimed at long term encapsulation of cell to be 
immunologically isolated. Ideally, the rate of scaffold degradation should mirror the 
rate of new tissue formation or be adequate for controlled release of bioactive 
molecules [69]. Furthermore, the biomaterial should provide an environment in 
which appropriate regulation of cell behavior (e.g., adhesion, proliferation, 
migration, and differentiation) can occur such that functional tissue can form [81]. 
 
Therefore, biomaterials that are intended for use as tissue engineering 
templates must exhibit several general requirements (i.e. biocompatibility, 
degradability, osteoconductivity, and mechanical integrity) [83], in order to 
efficiently perform the function for which they are designed for. The final application 
of the materials will dictate the type of tissue engineering approach to use and 
consequently the type of construct needed. 
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2.6.2  Calcium phosphate ceramics 
Calcium phosphate-based bioceramics have been in used in medicine and 
dentistry for nearly 20 years. Applications include coating of orthopedic and dental 
implants, maxillofacial surgery, and scaffolds for bone growth and as powders in 
total hip and knee surgery [84]. 
 
Synthetically prepared calcium phosphates are chemically similar to the 
mineral phase of natural bone tissue, which is a carbonated, calcium-deficient impure 
hydroxyapatite [10, 56, 85]. Many different biocompatible calcium phosphate 
species may be prepared to participate actively in the bone remodeling process, 
although only those that have a molar calcium-to-phosphorous ratio equal to or 
greater than 1.0 have been reported to be biocompatible and acceptable for use in 
physiological applications [86]. 
 
Calcium phosphate has been synthesized and used for manufacturing various 
forms of implants, as well as for solid or porous coatings on other implants. There 
are mono-, di-, tri-, and tetra-calcium phosphates, in addition to the hydroxyapatite 
and β-whitlockite, which have ratios of 5/3 and 3/2 for calcium and phosphorus 
(Ca/P), respectively. The stability in solution generally increases with increasing 
Ca/P ratios [5, 87, 88]. Different phases are used in different applications depending 
upon whether a degradable or a bioactive material is desired [89].  
 
The stable phases of calcium phosphate ceramics depend considerably upon 
temperature and the presence of water, either during processing or in the use 
environment. At body temperature, only two calcium phosphates are stable in contact 
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with aqueous media, such as body fluids; at pH < 4.2, the stable phase is calcium 
hydrogen phosphate dehydrate (DCPD: CaHPO4•2H2O or brushite, C2P), whereas at 
pH ≥ 4.2, the stable phase is hydroxyapatite (HA: Ca10(PO4)6(OH)2) [90]. At higher 
temperatures, other phases, such as tricalcium phosphate (TCP: Ca3(PO4)2 or C3P) 
and tetracalcium phosphate (Ca4P2O9) are present. The unhydrated, high-temperature 
calcium phosphate phases interact with water, or body fluids at 37
o
C to form HA. 
Thus, the solubility of a TCP surface approaches the solubility of HA and decreases 
the pH of the solution which further increases the solubility of TCP and enhances 
resorption [91].  
 
The rate of dissolution increases as the calcium to phosphorus ratio drops. 
Hence, tricalcium phosphate resorbs faster than HA. Tricalcium phosphate has four 
forms; α, β, γ and super α. However, the most commonly used forms for medical 
applications are the α and β forms. The α-TCP phase crystallizes into a monoclinic 
space group with a theoretical density of 2.863 g/cm
3. The β-TCP phase has a 
rhombohedral structure and a theoretical density calculated to be 3.067 g/cm
3
 [86]. 
Research has shown that the α form dissolves at a faster rate than β-TCP. Animal 
studies have demonstrated that the α form degraded significantly more quickly than 
the β form after 4 weeks following implantation [92]. Other factors that influence the 
degradation rate of calcium phosphates are summarized in Table 2.4. 
Table 2.4 Factors influencing degradation rate of calcium phosphate [86] 
Directly Proportional Inversely Proportional 
Increasing surface area Crystallinity 
Substitution: CO3
2-
, Mg
2+
, Si, Sr
2+
 (in 
HA) 
Crystal perfection 
 
Grain size 
Substitution: F
-
, Mg
2+
 (in β) 
Ca:P ratio 
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Precipitation method is commonly used to fabricate synthetic calcium 
phosphate. Starting powders can be made by mixing into an aqueous solution the 
appropriate molar ratios of calcium and phosphate sources which yield a precipitate 
of stoichiometric HA. The Ca
2+
, PO4
3-
 and OH
-
 ions can be replaced by other ions 
during processing or in physiological surroundings; e.g., fluorapatite and carbonated 
apatite. Flourapatite is found in dental enamel and carbornated apatite is present in 
bone [84]. 
 
Depending on the final firing conditions, the calcium phosphate can be 
hydroxyapatite or β-TCP. In many instances, however, both type of structure exist in 
the same final product. Several types of CaP biomaterials (Table 2.5) differing in 
origin, composition and physical forms like particulates or blocks, coating on dental 
and orthopaedic metal implant are used in maxillo-facial contruction; ear implant; 
bone repair and augmentation [90, 93]. 
 
Table 2.5 Calcium phosphates used in tissue engineering [94] 
Name and chemical 
formula 
Ca/P molar 
ratio 
Abbreviation 
Type of materials and 
utilization 
Hydroxyapatite 
Ca10(PO4)6(OH)2 
1.67 HA 
ceramics, 
plasma sprayed coatings, 
composites, 
drug carrier 
Calcium deficient apatites <1.67 ns-HA 
low temperature coating 
composites, drug carrier 
α and β tricalcium 
phosphates 
Ca3(PO4)2 
1.50  and  TCP cements 
Dicalcium phosphate 
dihydrate 
CaHPO4•2H2O 
1.0 DCPD cements, coating 
Anhydrous dicalcium 
phosphate 
CaHPO4 
1.0 DCPA cements, coating 
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Table 2.5 (Cont.) Calcium phosphates used in tissue engineering 
 
2.6.2.1 Hydroxyapatite 
Hydroxyapatite (HA) is the most important among the calcium compounds 
since it is found in natural hard tissues as a mineral bioceramic phase. Among the 
most interesting properties of hydroxyapatite as a biomaterial is its excellent 
biocompatibility. It appears to form a direct chemical bond with hard tissue. In 
addition, hydroxyapatite acts as a reinforcement in hard tissues and is responsible for 
the stiffness of bone, dentine, and enamel [77]. 
 
According to Park and Lake [95], the mineral part of bone and teeth is made 
of a crystalline form of calcium phosphate similar to hydroxyapatite. The apatite 
family of mineral crystallizes into hexagonal rhombic prisms, with the space group 
being P63/m and has unit cell dimensions a = 9.432 Ȧ and c = 6.875 Ȧ. The unit cell 
contains a complete representation of the apatite crystal, consisting of Ca
2+
, PO4
3-
, 
and OH
-
 groups closely packed together in arrangement shown in Figure 2.3. The 
hydroxyl ions lie on the corners of the projected basal plane and they occur at an 
Name and chemical 
formula 
Ca/P molar 
ratio 
Abbreviation 
Type of materials and 
utilization 
 
Octocalcium phosphate 
Ca8(PO4)4 
(HPO4)2, 5H2O 
 
1.33 
 
OCP 
 
cements, bone graft 
Tetracalcium phosphate 
Ca4(PO4)2O 
2.0 TTCP 
cements, drug carrier 
low temperature coating 
Amorphous calcium 
phosphate 
1.5-3.0 ACP 
cements, drug carrier 
low temperature coating 
Biphasic calcium 
phosphate 
1.55-1.66 
BCP 
HA/β-TCP 
bonegraft, coatings 
Fluorapatite, 
Ca10(PO4)6F2 
1.67 FA bonegraft, coating 
Carbonated hydroxyapatite 
(Ca,Na)10(PO4,CO3)6(OH)2 
1.7-2.6 CHA bonegraft 
